Company Filing History:
Years Active: 2013-2016
Title: Inventor Spotlight: Wen-Hsing Lin
Introduction
Wen-Hsing Lin is an accomplished inventor based in Miaoli County, Taiwan. With a strong focus on developing innovative compounds, he has made significant contributions to the field of medicinal chemistry, particularly in the area of protein kinase inhibitors. His expertise is reflected in the patents he holds, which aim to advance the understanding and treatment of various diseases.
Latest Patents
Wen-Hsing Lin is credited with two notable patents. The first patent involves “Pyrazole compounds and thiazole compounds as protein kinases inhibitors.” This patent describes a compound formula where specific variables A, B, D, X, Y, R, m, p, and q are defined in detail. It also outlines methods for inhibiting FMS-like tyrosine kinase 3, aurora kinase, and vascular endothelial growth factor receptor, showcasing his commitment to tackling complex medical challenges.
His second patent is focused on “Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors.” This patent describes various fused bicyclic or tricyclic compounds and provides methods for inhibiting EGFR kinase activity while offering potential therapeutic strategies for cancer treatment using these innovative compounds.
Career Highlights
Wen-Hsing Lin is affiliated with the National Health Research Institutes, an organization dedicated to health-related research and innovation. His work contributes to the overarching goal of improving health outcomes through scientific advancements. Lin's focus on developing novel compounds positions him as a relevant figure in the field, and his patents reflect the cutting-edge research being conducted at his institute.
Collaborations
Throughout his career, Wen-Hsing Lin has collaborated with notable colleagues, including Tsu-An Hsu and Yu-Sheng Chao. These partnerships highlight the importance of collaborative efforts in research, promoting the exchange of ideas and enhancing the innovation process within the field of medicinal chemistry.
Conclusion
Wen-Hsing Lin's dedication to innovation in the realm of protein kinase inhibitors demonstrates the vital role of inventors in advancing scientific knowledge and healthcare solutions. His contributions, encapsulated in his recent patents, underscore the importance of research and collaboration in the development of effective therapeutic strategies. As he continues his work at the National Health Research Institutes, the impact of his inventions is likely to resonate well beyond the laboratory.